Shardul Amarchand Mangaldas & Co. advises DZ Bank AG, Frankfurt in the corporate insolvency resolution process of Sintex Industries Limited

Shardul Amarchand Mangaldas & Co. advised DZ Bank AG, Frankfurt (as offshore ECB lender) in relation to its exposure to Sintex Industries Limited (Sintex) which was undergoing corporate insolvency resolution process (CIRP) under the Insolvency and Bankruptcy Code, 2016.   SAM & Co. team assisted DZ Bank AG through the CIRP of Sintex in the… Read More +

countinue reading

Shardul Amarchand Mangaldas advises Mankind Pharma Limited on its initial public offering of equity shares aggregating to ₹ 4,326.35 crore

Shardul Amarchand Mangaldas & Co. advised Mankind Pharma Limited on its initial public offering (IPO) of equity shares, comprising an offer for sale by promoter-selling shareholders and private equity investors (affiliates of Chrys Capital and Capital Group). The deal was valued at ₹ 4,326.35 crore and the equity shares are proposed to be listed on… Read More +

countinue reading

Shardul Amarchand Mangaldas & Co. advises Raymond Consumer Care Limited on the slump sale of it’s FMCG business undertaking to Godrej Consumer Products Limited

Shardul Amarchand Mangaldas advised Raymond Consumer Care Limited on the transfer of it’s FMCG business undertaking (which includes well-known trademarks such as Park Avenue, K.S., Kamasutra and Premium) to Godrej Consumer Products Limited, on a slump sale basis. The date of signing the deal was 27 April 2023 and the deal was valued at INR… Read More +

countinue reading